Abstract
The protein kinase C (PKC) family of isoenzymes is believed to mediate a wide range of signal-transduction pathways in many different cell types. A series of bisindolylmaleimides have been evaluated as inhibitors of members of the conventional PKC family (PKCs-alpha, -beta, -gamma) and of a representative of the new, Ca(2+)-independent, PKC family, PKC-epsilon. In contrast with the indolocarbazole staurosporine, all the bisindolylmaleimides investigated showed slight selectivity for PKC-alpha over the other isoenzymes examined. In addition, bisindolylmaleimides bearing a conformationally restricted side-chain were less active as inhibitors of PKC-epsilon. Most noticeable of these was Ro 32-0432, which showed a 10-fold selectivity for PKC-alpha and a 4-fold selectivity for PKC-beta I over PKC-epsilon.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asaoka Y., Nakamura S., Yoshida K., Nishizuka Y. Protein kinase C, calcium and phospholipid degradation. Trends Biochem Sci. 1992 Oct;17(10):414–417. doi: 10.1016/0968-0004(92)90011-w. [DOI] [PubMed] [Google Scholar]
- Bit R. A., Davis P. D., Elliott L. H., Harris W., Hill C. H., Keech E., Kumar H., Lawton G., Maw A., Nixon J. S. Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction. J Med Chem. 1993 Jan 8;36(1):21–29. doi: 10.1021/jm00053a003. [DOI] [PubMed] [Google Scholar]
- Borner C., Guadagno S. N., Fabbro D., Weinstein I. B. Expression of four protein kinase C isoforms in rat fibroblasts. Distinct subcellular distribution and regulation by calcium and phorbol esters. J Biol Chem. 1992 Jun 25;267(18):12892–12899. [PubMed] [Google Scholar]
- Davis P. D., Elliott L. H., Harris W., Hill C. H., Hurst S. A., Keech E., Kumar M. K., Lawton G., Nixon J. S., Wilkinson S. E. Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J Med Chem. 1992 Mar 20;35(6):994–1001. doi: 10.1021/jm00084a004. [DOI] [PubMed] [Google Scholar]
- Davis P. D., Hill C. H., Keech E., Lawton G., Nixon J. S., Sedgwick A. D., Wadsworth J., Westmacott D., Wilkinson S. E. Potent selective inhibitors of protein kinase C. FEBS Lett. 1989 Dec 18;259(1):61–63. doi: 10.1016/0014-5793(89)81494-2. [DOI] [PubMed] [Google Scholar]
- Davis P. D., Hill C. H., Lawton G., Nixon J. S., Wilkinson S. E., Hurst S. A., Keech E., Turner S. E. Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides. J Med Chem. 1992 Jan;35(1):177–184. doi: 10.1021/jm00079a024. [DOI] [PubMed] [Google Scholar]
- Elliott L. H., Wilkinson S. E., Sedgwick A. D., Hill C. H., Lawton G., Davis P. D., Nixon J. S. K252a is a potent and selective inhibitor of phosphorylase kinase. Biochem Biophys Res Commun. 1990 Aug 31;171(1):148–154. doi: 10.1016/0006-291x(90)91369-4. [DOI] [PubMed] [Google Scholar]
- Gschwendt M., Leibersperger H., Kittstein W., Marks F. Protein kinase C zeta and eta in murine epidermis. TPA induces down-regulation of PKC eta but not PKC zeta. FEBS Lett. 1992 Jul 28;307(2):151–155. doi: 10.1016/0014-5793(92)80756-7. [DOI] [PubMed] [Google Scholar]
- House C., Kemp B. E. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science. 1987 Dec 18;238(4834):1726–1728. doi: 10.1126/science.3686012. [DOI] [PubMed] [Google Scholar]
- Marais R. M., Parker P. J. Purification and characterisation of bovine brain protein kinase C isotypes alpha, beta and gamma. Eur J Biochem. 1989 Jun 1;182(1):129–137. doi: 10.1111/j.1432-1033.1989.tb14809.x. [DOI] [PubMed] [Google Scholar]
- Mischak H., Kolch W., Goodnight J., Davidson W. F., Rapp U., Rose-John S., Mushinski J. F. Expression of protein kinase C genes in hemopoietic cells is cell-type- and B cell-differentiation stage specific. J Immunol. 1991 Dec 1;147(11):3981–3987. [PubMed] [Google Scholar]
- Murphy N. P., McCormack J. G., Ball S. G., Vaughan P. F. The effect of protein kinase C activation on muscarinic-M3- and K(+)-evoked release of [3H]noradrenaline and increases in intracellular Ca2+ in human neuroblastoma SH-SY5Y cells. Biochem J. 1992 Mar 15;282(Pt 3):645–650. doi: 10.1042/bj2820645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakanishi H., Brewer K. A., Exton J. H. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1993 Jan 5;268(1):13–16. [PubMed] [Google Scholar]
- Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992 Oct 23;258(5082):607–614. doi: 10.1126/science.1411571. [DOI] [PubMed] [Google Scholar]
- Osada S., Mizuno K., Saido T. C., Suzuki K., Kuroki T., Ohno S. A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle. Mol Cell Biol. 1992 Sep;12(9):3930–3938. doi: 10.1128/mcb.12.9.3930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schaap D., Parker P. J. Expression, purification, and characterization of protein kinase C-epsilon. J Biol Chem. 1990 May 5;265(13):7301–7307. [PubMed] [Google Scholar]
- Stabel S., Parker P. J. Protein kinase C. Pharmacol Ther. 1991;51(1):71–95. doi: 10.1016/0163-7258(91)90042-k. [DOI] [PubMed] [Google Scholar]
- Stabel S., Schaap D., Parker P. J. Expression of protein kinase C isotypes using baculovirus vectors. Methods Enzymol. 1991;200:670–673. doi: 10.1016/0076-6879(91)00179-z. [DOI] [PubMed] [Google Scholar]
- Wetsel W. C., Khan W. A., Merchenthaler I., Rivera H., Halpern A. E., Phung H. M., Negro-Vilar A., Hannun Y. A. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol. 1992 Apr;117(1):121–133. doi: 10.1083/jcb.117.1.121. [DOI] [PMC free article] [PubMed] [Google Scholar]